GERN keep your eye on this one | Biotech Message Board Posts


Biotech   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  45944 of 50622  at  5/12/2023 5:04:15 PM  by

skimklaw


 In response to msg 45943 by  Bronxboy50
view thread

Re: GERN keep your eye on this one

 I have been in GERN for years (so just recently above water).  Still a sizable position.  Transfusion burden is a problem in these diseases (MF/MDS) and this drug looks like a winner to me.  Stock is straight up with steady accumulation since the EHA data leak which started the run.  Durable transfusion independence is pretty impressive.  RS independent is nice too.  Lot of positive catalysts over next 12 months potentially.  
 
I don't feel like I have noted this kind of strength and follow through with GERN.  Last few times anything at all like this momentum was killed with secondary.  Seeing as GERN should be cashed up through approval and start of commercialization it is feeling a lot different and I feel like there is a chance that that EHA data piqued someone's interest or accelerated some accumulation timelines.
 
Either way if you would have told me you could buy GERN in January 2022 in May 2023 with the data read out that they had for 3 dollars I would say you were crazy. 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 6  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
45952 Re: GERN keep your eye on this one Bronxboy50 1 5/15/2023 8:55:02 AM




Financial Market Data provided by
.
Loading...